Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

The new formulation greatly improved quercetin absorption in rats.

Abrocitinib may effectively treat Lichen Planopilaris.

Cyclophosphamide severely damages the intestinal lining in rats.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Tofacitinib treatment for hair loss may worsen acne.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

Albizia saponaria bark extract at 20% concentration promotes hair growth in rabbits.

Rutin may protect against stomach damage caused by sodium valproate.

Baricitinib may effectively treat oral lichen planus.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.